Impact of Cadmium Exposure on Transporter Function and Drug Disposition in the Kidney
镉暴露对肾脏转运功能和药物分布的影响
基本信息
- 批准号:10442070
- 负责人:
- 金额:$ 36.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-05-24 至 2027-03-31
- 项目状态:未结题
- 来源:
- 关键词:AffectAnionsAntineoplastic AgentsAntiviral AgentsBiologicalBiological AssayCadmiumCardiovascular DiseasesCarrier ProteinsCationsCell membraneCell modelCellsChronicCisplatinClinicalCytoplasmic ProteinDiabetes MellitusDiseaseDose-LimitingDrug TransportDrug toxicityDrug usageFoundationsHalf-LifeHealthHeavy MetalsHumanHuman bodyIncidenceIndividualIntoxicationKidneyKnowledgeMalignant NeoplasmsMediatingMembraneMetalsMolecularMultidrug Resistance-Associated ProteinsMusOrganic Anion TransportersOrganic Cation TransporterPathway interactionsPharmaceutical PreparationsPharmacologyPharmacotherapyPharmacy (field)PoisonProteinsProteomicsProto-Oncogene Proteins c-aktPublicationsPublishingRegulationResearchRiskRoleSourceSystemTenofovirTestingTimeTissuesToxinTransmembrane TransportTubular formationUnited States Environmental Protection AgencyVariantapical membranebasebasolateral membranedisease registrydrug dispositionexposed human populationinhibitorinsightkidney cellmouse modelnephrotoxicitypollutantprotein transportresponseside effectsmall moleculetoxic metaltoxicanttraffickinguptake
项目摘要
PROJECT SUMMARY/ABSTRACT
The heavy metal cadmium (Cd) is currently ranked 7th on the 2019 US Agency for Toxic Substances and
Disease Registry (ATSDR) and listed as one of Priority Pollutants by US Environmental Protection Agency
(EPA). Although intoxication by high levels of Cd exposure is rarely seen nowadays, chronic low levels of Cd
exposure is still a major health concern as Cd is a cumulative metal with an extremely long biological half-life of
10-30 years in human body. Cd exposure has been associated with increased incidence of multiple diseases.
Strikingly, little is known whether chronic Cd exposure would affect the disposition of drugs that are used to treat
diseases. Renal transporter proteins involve in drug disposition by mediating drug transport across tubular cells
and particularly proximal tubules. Coordinated transcellular transport by uptake transporters, such as organic
cation transporters (OCTs) and organic anion transporters (OATs) in the basolateral membrane in concert with
efflux transporters, such as multidrug and toxin extrusion proteins (MATEs) and multidrug resistance-associated
proteins (MRPs) in the apical membrane of tubular cells, is believed to be an essential system for renal
disposition of cationic and anionic drugs, respectively. Our recent publications and current preliminary results
indicate a broad effect by chronic Cd exposure on renal transporters including OCTs, MATEs, OATs and MRPs.
However, the detail mechanism of transporter regulation by Cd and its broad impact on drug disposition and
response remain to be illustrated. We hypothesize that chronic Cd exposure could alter renal transporter
function, resulting in alteration in drug disposition and toxicity in the kidney. To test this hypothesis, we propose
to conduct research with three specific Aims. Firstly, by using a variety of cellular and molecular assays, along
with proteomic approach, we will uncover a molecular mechanism by which chronic Cd exposure enhances the
translocation of OCT and OAT uptake proteins from the cytoplasmic pool to cell membrane and consequently
increase the cellular accumulation of small molecules that are the substrates of these transporters (Aim 1). Most
clinical used drugs are either organic cations or organic anions. We then propose to demonstrate the impact of
Cd exposure on the disposition of cationic drugs by investigating the effects of Cd exposure on OCT and MATE
expression in mouse kidney tissues and human renal cells, and particularly the impact on cisplatin disposition
and nephrotoxicity using Oct1/2- and Mate1-deficinet mice (Aim 2). Lastly, the effects of chronic Cd exposure
on expression of the anionic drug transporters OATs and MRPs will be characterized in mouse kidney tissues
and human renal cells, and specifically Cd impact on the disposition and nephrotoxicity of the antiviral tenofovir
will be studied with Oat1/3-, Mrp4-deficient mice and OAT pharmacological inhibition (Aim 3). Successful
completion of this project will provide a foundation to uncover environmental Cd as a previously unrecognized
factor for the broad variation in drug disposition and response, contributing to a better drug theray.
项目摘要/摘要
重金属镉(Cd)目前在2019年美国有毒物质管理局排名第7位,
美国毒物与疾病登记署(ATSDR),并被美国环境保护署列为优先污染物之一
(EPA)。虽然高浓度镉中毒现在很少见,但慢性低浓度镉中毒
接触镉仍然是一个主要的健康问题,因为镉是一种累积金属,具有极长的生物半衰期,
在人体内10-30年。镉暴露与多种疾病的发病率增加有关。
引人注目的是,很少有人知道慢性镉暴露是否会影响用于治疗的药物的处置。
疾病肾转运蛋白通过介导药物跨肾小管细胞转运参与药物的处置
特别是近端小管。通过摄取转运蛋白协调跨细胞转运,如有机
基底外侧膜中的阳离子转运蛋白(OCT)和有机阴离子转运蛋白(OAT)与
外排转运蛋白,如多药和毒素外排蛋白(MATE)和多药耐药相关的
肾小管上皮细胞顶膜中的MRPs被认为是肾功能的重要系统。
阳离子和阴离子药物的处置。我们最近的出版物和目前的初步结果
表明慢性镉暴露对肾脏转运蛋白(包括OCT、MATE、OAT和MRP)的广泛影响。
然而,镉对转运蛋白调控的详细机制及其对药物处置和代谢的广泛影响,
反应仍有待说明。我们假设慢性镉暴露可以改变肾脏转运蛋白,
功能,导致药物处置和肾脏毒性的改变。为了验证这一假设,我们建议
研究有三个具体目标。首先,通过使用各种细胞和分子测定,沿着
通过蛋白质组学方法,我们将揭示慢性镉暴露增强细胞凋亡的分子机制。
OCT和OAT摄取蛋白从细胞质池易位至细胞膜,
增加作为这些转运蛋白底物的小分子的细胞积累(目的1)。最
临床使用的药物是有机阳离子或有机阴离子。然后,我们建议证明的影响,
镉暴露对OCT和MATE的影响
在小鼠肾组织和人肾细胞中的表达,特别是对顺铂处置的影响
和肾毒性使用Oct 1/2-和Mate 1-deficinet小鼠(目的2)。最后,慢性镉暴露的影响
将在小鼠肾组织中表征阴离子药物转运蛋白OAT和MRP的表达
和人肾细胞,特别是镉对抗病毒替诺福韦的处置和肾毒性的影响
将使用Oat 1/3-、Mrp 4-缺陷小鼠和OAT药理学抑制进行研究(目的3)。成功
该项目的完成将提供一个基础,揭示环境镉作为一个以前未被认识到的
药物处置和反应的广泛变化的因素,有助于更好的药物治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yan Shu其他文献
Yan Shu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yan Shu', 18)}}的其他基金
Axin Stabilization by Novel Small Molecules to Treat Non-alcoholic Steatohepatitis
新型小分子稳定轴蛋白治疗非酒精性脂肪性肝炎
- 批准号:
10659312 - 财政年份:2023
- 资助金额:
$ 36.37万 - 项目类别:
Impact of Cadmium Exposure on Transporter Function and Drug Disposition in the Kidney
镉暴露对肾脏转运功能和药物分布的影响
- 批准号:
10626140 - 财政年份:2022
- 资助金额:
$ 36.37万 - 项目类别:
Xenobiotic Transporter Regulation and IRIP Function
异生物质转运蛋白调节和 IRIP 功能
- 批准号:
8699790 - 财政年份:2012
- 资助金额:
$ 36.37万 - 项目类别:
Xenobiotic Transporter Regulation and IRIP Function
异生物质转运蛋白调节和 IRIP 功能
- 批准号:
9096182 - 财政年份:2012
- 资助金额:
$ 36.37万 - 项目类别:
Xenobiotic Transporter Regulation and IRIP Function
异生物质转运蛋白调节和 IRIP 功能
- 批准号:
8534794 - 财政年份:2012
- 资助金额:
$ 36.37万 - 项目类别:
Xenobiotic Transporter Regulation and IRIP Function
异生物质转运蛋白调节和 IRIP 功能
- 批准号:
8369927 - 财政年份:2012
- 资助金额:
$ 36.37万 - 项目类别:
Xenobiotic Transporter Regulation and IRIP Function
异生物质转运蛋白调节和 IRIP 功能
- 批准号:
8883573 - 财政年份:2012
- 资助金额:
$ 36.37万 - 项目类别:
相似海外基金
CAS-Climate: Understanding the fundamental redox chemistry and transport of chloroaluminate anions in ionic liquid electrolytes to develop earth-abundant aluminum ion battery
CAS-Climate:了解离子液体电解质中氯铝酸盐阴离子的基本氧化还原化学和传输,以开发地球上丰富的铝离子电池
- 批准号:
2427215 - 财政年份:2024
- 资助金额:
$ 36.37万 - 项目类别:
Standard Grant
Reactivity and photochemistry of halide anions: atmospheric implications
卤化物阴离子的反应性和光化学:大气影响
- 批准号:
DP240100612 - 财政年份:2024
- 资助金额:
$ 36.37万 - 项目类别:
Discovery Projects
RUI: Characterizing Valence, Temporary, and Non-valence Anions: Computational Methods and Photo-detachment Spectroscopy
RUI:表征化合价、临时和非化合价阴离子:计算方法和光分离光谱
- 批准号:
2303652 - 财政年份:2023
- 资助金额:
$ 36.37万 - 项目类别:
Continuing Grant
Novel Catalysis by Lewis Acid Weakly Coordinated Anions
路易斯酸弱配位阴离子的新型催化
- 批准号:
23KJ0761 - 财政年份:2023
- 资助金额:
$ 36.37万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Controlling Coordination Octahedral Rotation and Inducing Ferroelectricity in Layered Perovskite Oxides with Intercalated Anions
插层阴离子层状钙钛矿氧化物中控制配位八面体旋转并诱导铁电性
- 批准号:
23H01869 - 财政年份:2023
- 资助金额:
$ 36.37万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Effects of mixed anions and passivation on perovskite solar cells fabricated by vapor-phase deposition
混合阴离子和钝化对气相沉积钙钛矿太阳能电池的影响
- 批准号:
23K04656 - 财政年份:2023
- 资助金额:
$ 36.37万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
RUI: Post-synthetic transformations of anions in metal chalcogenide nanoparticles: Uncovering synthetic design rules and the effect on subsequent transformations
RUI:金属硫族化物纳米颗粒中阴离子的合成后转化:揭示合成设计规则以及对后续转化的影响
- 批准号:
2312618 - 财政年份:2023
- 资助金额:
$ 36.37万 - 项目类别:
Standard Grant
Donor-Stabilized Fluorido Cations and New Tungsten-Based Weakly Coordinating Anions
供体稳定的氟阳离子和新型钨基弱配位阴离子
- 批准号:
RGPIN-2022-03698 - 财政年份:2022
- 资助金额:
$ 36.37万 - 项目类别:
Discovery Grants Program - Individual
CAS-Climate: Understanding the fundamental redox chemistry and transport of chloroaluminate anions in ionic liquid electrolytes to develop earth-abundant aluminum ion battery
CAS-Climate:了解离子液体电解质中氯铝酸盐阴离子的基本氧化还原化学和传输,以开发地球上丰富的铝离子电池
- 批准号:
2208744 - 财政年份:2022
- 资助金额:
$ 36.37万 - 项目类别:
Standard Grant
CAS-Climate:Collaborative Research:Understanding How Electrochemical Cation Trapping in Metal Oxides Enhances Subsequent Reversible Insertion of Anions in Forming Metal Oxyhalides
CAS-气候:合作研究:了解金属氧化物中的电化学阳离子捕获如何增强随后形成金属卤氧化物时阴离子的可逆插入
- 批准号:
2221646 - 财政年份:2022
- 资助金额:
$ 36.37万 - 项目类别:
Standard Grant